Update: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities. Douglas J. Hartman, MD June 7, 2018

Similar documents
ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016

Mesothelioma Pathobasic. Lukas Bubendorf Pathology

Malignant pleural mesothelioma (MPM) is a rare tumor

Biopsy Interpretation of Spindle cell proliferations of the Serosa

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

GUT-C 11/30/2017. Debasmita Das, M.D. PGY-1 Danbury Hospital

Enterprise Interest None

Salivary Glands 3/7/2017

Ground Glass Opacities

Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק

Histologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated With Extrapleural Pneumonectomy

POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?

Breast pathology. 2nd Department of Pathology Semmelweis University

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case 4 Diagnosis 2/21/2011 TGB

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Histopathology of NSCLC, IHC markers and ptnm classification

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

FINALIZED SEER SINQ S NOVEMBER 2011

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Diffuse malignant pleural mesothelioma (DMPM) is the

Melanoma Update: 8th Edition of AJCC Staging System

ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW

ACCME/Disclosures. Case 4 USCAP Pulmonary Panel Case 4 History

3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Lung Cancer T STAGE OUTLINE SURVIVAL ACCORDING TO SIZE ONLY

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for Rare Peritoneal Disease. Results of the French multicentric database

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.

Interesting Case Series. Desmoplastic Melanoma

Interactive Staging Bee

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach

Staging and Grading Last Updated Friday, 14 November 2008

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami

Human Papillomavirus and Head and Neck Cancer. Ed Stelow, MD

Neuroendocrine neoplasms of the lung

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk

04/09/2018. Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Select problems in cystic pancreatic lesions

The Pathology of Neoplasia Part II

Surgical Pathology Issues of Practical Importance

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

BLADDER CANCER EPIDEMIOLOGY

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Središnja medicinska knjižnica

Basement membrane in lobule.

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

Pathology of the Thyroid

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

Non-Small Cell Lung Carcinoma - Myers

Carcinoma of the Urinary Bladder Histopathology

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

The Enigmatic Spitz Lesion

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology

57th Annual HSCP Spring Symposium 4/16/2016

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Lung cancer is now a major cause of death in developed

Michael T. Tetzlaff MD, PhD

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

Pre-operative assessment of patients for cytoreduction and HIPEC

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS

encapsulated thyroid nodule with a follicular architecture and some form of atypia. The problem is when to diagnose

Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma

Low-grade serous neoplasia. Robert A. Soslow, MD

Pathological Classification of Hepatocellular Carcinoma

Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Diploma examination. Dermatopathology: First paper. Tuesday 21 March Candidates must answer FOUR questions ONLY. Time allowed: Three hours

Financial disclosures

JMSCR Vol 05 Issue 11 Page November 2017

A Canine Case of Complex Carcinoma of the Mammary Gland with Metastasis to the Axillary Lymph Node

Pancreatic Cancer: The ABCs of the AJCC and WHO

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

Michael T. Tetzlaff MD, PhD

Neuroendocrine Lung Tumors Myers

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

Transcription:

Update: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities Douglas J. Hartman, MD June 7, 2018

Objectives Review Historical Features associated with prognosis Present and describe the histologic subtypes Discuss the reproducibility and impact on prognosis of histologic subtypes

TNM Staging (Pleural) Based on a 1994 workshop by the International Association for the Study of Lung Cancer (IASLC), a staging system for pleural mesothelioma was instituted in the 6 th (2006) and 7 th (2010) AJCC system Validation of staging system was studied in 2012 3101 patients were studied No evidence based recommendations could be made based on a lack of granular data 15 centers

TNM Staging (Pleural) Cont d Follow-up group from 29 centers was attempted to analyze the staging system 2460 patients were able to be analyzed 827 patients had pre-treatment info; 830 had post surgical data; 803 had both data elements Limited ability to influence staging parameters

AJCC Histologic Type (Pleural) Epithelioid Biphasic (at least 10% of either element) Sarcomatoid Desmoplastic

www.mesothelioma.com Pleural Mesothelioma

www.mesothelioma.com Peritoneal Mesothelioma

Historical Publications Distinguishing malignant vs benign Distinguishing metastasis vs mesothelioma Limited work separating out prognosis based on morphologic features

Peritoneal Mesothelioma Reported Elements (UPMC) Pathologic parameters (choose one option then delete the other option and delete this line) - Depth of invasion: Superficially invasive ( 0.5 mm) / Deeply invasive (>0.5mm) - Prominent desmoplasia: Yes / No - Mitotic count: 5/50 hpf / >5/50hpf - Nuclear grade: Low / High - Lymph node metastases: Yes / No - Sarcomatoid component: Yes / No (Assessment of CDKN2A/p16 and NF2 by FISH, and BAP1 and PD-L1 by immunohistochemistry are pending; the results will follow in an addendum)

Nuclear grade (Cerruto et al) I IV II III

Possible Epithelioid Subtypes

Reproducibility Studies for Epithelioid Subtypes Pleural Reproducibility Acinar Adenomatoid Micropapillary Solid Tubulopapillary Trabecular Peritoneal Reproducibility Tubulopapillary Micropapillary Trabecular Solid Pleomorphic Papillary Tubular

Epithelioid Subtypes in pictures

Options TUB Definitions of papillary lesions have overlapping descriptions TP P

Epithelioid Subtype Decisions?

Epithelioid Subtype Morphologies Pure Epithelioid Patterns rarely observed (19% in one study) Most frequently (41%) observe three epithelioid morphologies Solid subtype was most reproducible among four reviewers

Prognosis - Peritoneal Epithelioid Solid subtype associated with a shorter overall survival compared to tubulopapillary and micropapillary Mitotic index (>5/50 per high power field) associated with a poor survival Small study size ( 84 cases)

New Horizon 63 yo male who presented with abdominal pain and shortness of breath Diagnosed with malignant mesothelioma Treated with cisplatin and Alimta

Lymphocytic Response - Peritoneal Grade of lymphocytic host response None-mild Moderate Severe May be relevant; reproducibility studies need to be performed/image analysis

Summary Epithelioid subtype mesothelioma frequently shows multiple morphologic patterns Some morphologic patterns are associated with a lower survival Lack of reproducibility and low case series to evaluate limit the ability to study the significance of epithelioid subtype morphology Changing treatment paradigms will further complicate the assessment of epithelioid subtypes

References 1. Brcic L, Jakopovic M, Brcic I, et al. Reproducibility of histological subtyping of malignant pleural mesothelioma. Virchows Arch 2014. 465:679-685 2. Krasinskas AM, Borczuk AC, Hartman DJ, et al. Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma. Histopathology 2016. 68: 729-737. 3. Hartman DJ, Borczuk AC, Dacic S, et al. Reproducibility for histologic parameters in peritoneal mesothelioma. Human Pathology 2017. 67: 54-59. 4. Brcic L, Vlacic G, Quehenberger F, et al. Reproducibility of malignant pleural mesothelioma histopathologic subtyping. Arch Pathol Lab Med June 2018. 142: 747-752. 5. AJCC Cancer Staging Manual 8 th Edition 2017 6. www.mesothelioma.com